NASDAQ:TCDA
Delisted
Tricida Inc Stock News
$0.108
+0 (+0%)
At Close: Apr 21, 2023
Tricida to Provide an End-of-Year Business Update
04:05pm, Monday, 07'th Dec 2020
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug cand
Tricida Shareholder Notice
10:23am, Saturday, 05'th Dec 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Shareholder Alert
09:22pm, Tuesday, 01'st Dec 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Investor Alert
08:33pm, Monday, 30'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Investor Alert
08:33pm, Tuesday, 24'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Shareholder Notice
08:44pm, Friday, 20'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Shareholder Alert
11:02am, Sunday, 15'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Investor Alert
08:19pm, Wednesday, 11'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Announces Third Quarter 2020 Financial Results
04:05pm, Monday, 09'th Nov 2020
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug cand
Tricida Investor Alert
08:55pm, Thursday, 05'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
TRICIDA SHAREHOLDER ALERT
10:52am, Sunday, 01'st Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York. New York--(Newsfile Cor
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tricida, Inc. - TCDA
08:30pm, Friday, 30'th Oct 2020
NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA). Such investors are advised to contact
Tricida Investor Alert
06:58pm, Thursday, 29'th Oct 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Tricida, Inc. To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Tricida Plunges To New Lows On 'Major Setback' For Drug Approval; Headcount Slashed By 61%
10:33am, Thursday, 29'th Oct 2020
Shares of Tricida Inc (NASDAQ: TCDA) were hitting new lows Thursday following a regulatory update on veverimer, the only investigational asset in its pipeline. What Happened: Following an end-of-rev
